PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $98,380 | -41.2% | 123,873 | 0.0% | 0.00% | – |
Q1 2024 | $167,229 | +33.7% | 123,873 | 0.0% | 0.00% | – |
Q4 2023 | $125,112 | +53.5% | 123,873 | 0.0% | 0.00% | – |
Q3 2023 | $81,508 | -30.1% | 123,873 | 0.0% | 0.00% | – |
Q2 2023 | $116,602 | -1.7% | 123,873 | 0.0% | 0.00% | – |
Q1 2023 | $118,633 | -65.3% | 123,873 | -50.0% | 0.00% | – |
Q4 2022 | $341,890 | +120.6% | 247,746 | +100.0% | 0.00% | – |
Q3 2022 | $155,000 | -46.9% | 123,873 | 0.0% | 0.00% | – |
Q2 2022 | $292,000 | -87.6% | 123,873 | -83.7% | 0.00% | – |
Q1 2022 | $2,357,000 | -48.2% | 760,352 | +6.1% | 0.00% | – |
Q4 2021 | $4,551,000 | -33.1% | 716,633 | +5.0% | 0.00% | – |
Q3 2021 | $6,799,000 | -71.9% | 682,627 | -62.7% | 0.00% | -100.0% |
Q2 2021 | $24,238,000 | -22.3% | 1,830,649 | +2.5% | 0.00% | -50.0% |
Q1 2021 | $31,206,000 | +209.8% | 1,785,237 | +353.2% | 0.00% | +100.0% |
Q4 2020 | $10,072,000 | +233.7% | 393,916 | +71.1% | 0.00% | – |
Q3 2020 | $3,018,000 | -44.5% | 230,211 | +15.7% | 0.00% | – |
Q2 2020 | $5,438,000 | – | 198,966 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |